| Size | Price | Stock |
|---|---|---|
| 1mg | $170 | In-stock |
| 5mg | $540 | In-stock |
| 10mg | $860 | In-stock |
| 25mg | $1380 | In-stock |
| 50mg | $1794 | In-stock |
| 100mg | $2200 | In-stock |
| 200 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-107543 |
| M.Wt: | 507.82 |
| Formula: | C17H16ClN5NaO6PS |
| Purity: | >98 % |
| Solubility: | DMSO : 125 mg/mL (ultrasonic;warming;heat to 60°C) |
8-pCPT-2′-O-Me-cAMP (8-CPT-2'-O-Me-cAMP) sodium, an analog of cAMP, is an activator of exchange proteins activated by cAMP (Epac). 8-pCPT-2′-O-Me-cAMP sodium activates Epac1 (EC50 = 2.2 μM), but not PKA (EC50 >10 μM). 8-pCPT-2′-O-Me-cAMP sodium stimulates Epac-mediated Ca2+ release in pancreatic β-cells in vitro. 8-pCPT-2′-O-Me-cAMP sodium is a Rap1 activator. 8-pCPT-2′-O-Me-cAMP sodium enhances the retinal pigment epithelium barrier against the pathological choroidal endothelial cell invasion that occurs in macular degeneration[1][2][3]. In Vitro:8-CPT-2'-O-Me-cAMP (250 µM; 1 h) sodium induces Rap1 activation and enhances recruitment of junctional proteins and cortical F-actin in retinal pigment epithelium cells[1]. In Vivo:8-CPT-2'-O-Me-cAMP (2.05 µM; 1 µL; intravitreal injection) sodium inhibits development of choroidal neovascular lesions in a laser-injury modl[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.